BiotechTube
Home/Neurofix/Miguel Ángel Ávila
MÁ

Miguel Ángel Ávila

CEO

Neurofix

Therapeutic Areas

NeurologyPain

Neurofix Pipeline

DrugIndicationPhase
NFX88Neuropathic pain from spinal cord injuryPhase 2

Leadership Team at Neurofix

JM
Juan Manuel Corchado Rodríguez
Independent Advisor
View full Neurofix profile